Bronchial hyperresponsiveness in an adult population in Helsinki: Decreased FEV1, the main determinant

Clinical Respiratory Journal

Volumn 7, Issue 1, 2013, Pages 34-44

  Juusela, Maria ^a   Pallasaho, Paula ^b   Sarna, Seppo ^c   Piirilä, Päivi ^a   Lundbäck, Bo ^d   Sovijärvi, Anssi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bronchial hyperresponsiveness; Histamine; Respiratory symptoms; Sensitization

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; BRONCHODILATION TEST; BRONCHUS DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EXAMINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPIROMETRY; STRUCTURED INTERVIEW; SWEDEN;

ADULT; AGED; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; DATA COLLECTION; FEMALE; FINLAND; FORCED EXPIRATORY VOLUME; HISTAMINE; HISTAMINE AGONISTS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SKIN TESTS; SPIROMETRY;

EID: 84875679625     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2012.00279.x     Document Type: Article

References (47)

1. Woolcock A, Peat J, Salome C, Yan K, Anderson S, Schoeffel R, McCowage G, Killalea T. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987;42: 361-8.
2. Nowak D, Heinrich J, Jörres R, Wassmer G, Berger J, Beck E, Boczor S, Claussen M, Wichmann H, Magnussen H. Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults: West and East Germany. Eur Respir J. 1996;9: 2541-52.
3. Norrman E, Plaschke P, Björnsson E, Resenhall L, Lundbäck B, Jansson C, Lindholm N, Boman G. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respir Med. 1998;92: 480-7.
4. Toelle B, Xuan W, Peat J, Marks G. Childhood factors that predict asthma in young adulthood. Eur Respir J. 2004;23: 66-70.
5. Lundbäck B, Stjernberg N, Rosenhall L, Lindström M, Jönsson E, Andersson S. Methacholine reactivity and asthma. Report from the Northern Sweden Obstructive Lung Disease Project. Allergy. 1993;48: 117-24.
6. Pallasaho P, Lundback B, Läspä S, Jönsson E, Kotaniemi J, Sovijärvi AR, Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study. Respir Med. 1999;93: 798-809.
7. Kotaniemi J, Lundbäck B, Nieminen M, Sovijärvi AR, Laitinen LA. Increase of asthma in adults in Northern Finland? - a report from the FinEsS study. Allergy. 2001;56: 169-74.
8. Juusela M, Poussa T, Kotaniemi J, Lundbäck B, Sovijärvi A. Bronchial hyperresponsiveness in a population of North Finland with no previous diagnosis of asthma or chronic bronchitis assessed with histamine and metacholine tests. Int J Circumpolar Health. 2008;67: 308-17.
9. Karjalainen E-M, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161: 2086-91.
10. Torchio R, Gulotta C, Ciacco C, Perboni A, Guglielmo M, Crosa F, Zerbini M, Brusasco V, Hyat R, Pellegrino R. Effects of chest wall strapping on mechanical response to methacholine in humans. J Appl Physiol. 2006;101: 430-8.
11. Moreno R, Hogg J, Paré P. Mechanics of airway narrowing. Am Rev Respir Dis. 1986;133: 1171-80.
12. Downie S, Salome C, Verbanck S, Thompson B, Berend N, King G. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax. 2007;62: 684-9.
13. Tgavalekos N, Musch G, Harris R, Melo M, Winkler T, Schroeder T, Callahan R, Lutchen K, Venegas J. Relationship between airway narrowing, patchy ventilation and lung mechanics in asthmatics. Eur Respir J. 2007;29: 1174-81.
14. Harris S, Winkler T, Tgavalekos N, Musch G, Melo M, Schroeder T, Chang Y, Venegas J. Regional pulmonary perfusion, inflation, and ventilation defects in bronchoconstricted patients with asthma. Am J Respir Crit Care Med. 2006;174: 245-53.
15. Janson C, Chinn S, Jarvis D, Zock J-P, Toren K, Burney P. Effects of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet. 2001;358: 2103-9.
16. Chinn S, Jarvis D, Luczynska C, etal. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med. 2005;172: 956-61.
17. Pistelli F, Bottai M, Carrozzi L, DiPede F, Baldacci S, Maio S, Brusasco V, Pellegrino R, Viegi G. Changes in obesity status and lung function decline in a general population sample. Respir Med. 2008;102: 674-80.
18. Scichilone N, Messina M, Battaglia S, Catalano F, Bellia V. Airway hyperresponsiveness in the elderly: prevalence and clinical implications. Eur Respir J. 2005;25: 364-75.
19. Brutsche M, Downs S, Schindler C, Gerbase M, Schwartz J, Frey M, Russi E, Ackermann-Liebrich U, Leuenberger P. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax. 2006;61: 671-7.
20. Boutet K, Malo J-L, Ghezzo H, Gautrin D. Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax. 2007;62: 260-4.
21. Chinn S, Schouten JP. Reproducibility of non-specific bronchial challenge in adults: implications for design, analysis and interpretation of clinical and epidemiological studies. Thorax. 2005;60: 395-400.
22. Curjuric I, Zemp E, Dratva J, etal. the SAPALDIA team. Determinants of change in airway reactivity over 11 years in the SAPALDIA population study. Eur Respir J. 2011;37: 492-500.
23. Pallasaho P, Rönmark E, Haahtela T, Sovijärvi A, Lundbäk B. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy. 2006;36: 503-9.
24. Viljanen AA, Haltunen P, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest. 1982;42(Suppl. 159): 5-20.
25. 6, FVC, and forced expiratory time. A report from the FinEsS-Helsinki II study. Dissertation, Helsinki University 2008.
26. Rouhos A. Clinical aspects of exhaled nitric oxide in adults: associations with atopy, bronchial hyperresponsiveness, smoking and chronic obstruction. Dissertation, Helsinki University 2010.
27. Pallasaho P. Prevalence and determinants of respiratory symptoms, asthma, chronic bronchitis and allergic sensitazation in Helsinki. A comparison between Finland, Sweden and Estonia. The FinEsS studies - Helsinki I. Dissertation, Helsinki University 2006.
28. Cline MG, Burrows B. Research overview, distribution of allergy in a population sample residing in Tucson, Arizona. Thorax. 1989;44: 425-31.
29. The American Thoracic Society (ATS). Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152: 1107-36.
30. Sovijärvi A, Malmberg P, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest. 1993;104: 164-70.
31. Cockroft C, Murdock K, Mink J. Determination of histamine PC20; comparison of linear and logarithmic interpolation. Chest. 1983;84: 505-6.
32. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine. Am Rev Respir Dis. 1987;136: 1412-7.
33. Haahtela T, Kaila M, Ahonen E, Kava T, Kinnula T, Mäkelä M, Remes S, Sovijärvi A, Valovirta E. Astman Käypä Hoito - suositus. Duodecim. 2000;11: 2568-84. ja päivitys 19.5.2006 s.1-17. [The Finnish Guidelines for Asthma, in Finnish].
34. Chinn S, Burney P, Jarvis D, Luczynska C. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1997;10: 2495-501.
35. Schwartz J, Schindler C, Zemp E, Perruchoud A, Zellweger J-P, Wüthrich B, Leuenberger P, Ackermann-Liebrich U, SAPALDIA Team. Predictors of methacholine responsiveness in a general population. Chest. 2002;122: 812-20.
36. Kerkhof M, Postma D, Schouten J, Monchy J. Allergic sensitisation to indoor and outdoor allergens and relevance to bronchial hyperresponsiveness in younger and older subjects. Allergy. 2003;58: 1261-7.
37. Ekroos H, Rouhos A, Pallasaho P, Karjalainen J, Sarna S, Sovijärvi AR. Equally elevated concentrations of exhaled nitric oxide in nonatopic and low-sensitized atopic asthmatics. Respir Med. 2009;103: 152-8.
38. Bayat S, Strengell S, Porra L, Janosi TZ, Petak F, Suhonen H, Suortti P, Hantos Z, Sovijärvi AR, Habre W. Methacholine and ovalbumin challenges assessed by forced oscillations and synchrotron lung imaging. Am J Respir Crit Care Med. 2009;180: 296-303.
39. Chung KF. Asthma treatments: effects on the airway smooth muscle. In: Chung KF, editor. Airway Smooth Muscle in Asthma and COPD: Biology and Pharmacology. West Sussex; England, John Wiley & Sons, Ltd, 2008: 277-302.
40. Hewitt D. Interpretation of the 'positive' methacholine challenge. Am J Ind Med. 2008;51: 769-81.
41. Malo J, Pineau L, Cartier A, Martin R. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis. 1983;128: 8-11.
42. Jögi R, Janson C, Björnsson E, Boman G, Björksten B. Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy. 1998;28: 1072-80.
43. Sovijärvi A, Haahtela T, Ekroos H, Lindqvist A, Saarinen A, Poussa T, Laitinen L. Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment. Thorax. 2003;58: 500-4.
44. Jartti T, Lehtinen P, Vanto T, Vuorinen T, Hartiala J, Hiekkinen H, Malmberg P, Mäkelä M, Ruuskanen O. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol. 2007;18: 326-34.
45. Panickar J, Lakhanpaul M, Lambert P, Stephenson T, Smyth A, Grigg J. Oral prednisolone for preschool children with acute virus-induced wheezing. NEJM. 2009;360: 329-38.
46. Sterk P, Fabbri L, Quanjer P, Cockcroft D, O'Byrne P, Anderson S, Juniper E, Malo J. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitising stimuli in adults. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J. 1993;6(Suppl. 16): 53-83.
47. Altman DG, Bland JM. Diagnostic tests2: predictive values. BMJ. 1994;309: 102.